Cited by 748Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Open access

Garcia-Alloza, Monica, Robbins, Elissa M., Zhang-Nunes, Sandy X., Purcell, Susan M., Betensky, Rebecca A., Raju, Susan, Prada, Claudia, Greenberg, Steven M., Bacskai, Brian J., Frosch, Matthew P.·2006·Neurobiology of Disease

DOI 10.1016/j.nbd.2006.08.017

Open this paper in CoChat — free account

Abstract

Transgenic mice carrying disease-linked forms of genes associated with Alzheimer disease often demonstrate deposition of the beta-amyloid as senile plaques and cerebral amyloid angiopathy. We have characterized the natural history of beta-amyloid deposition in APPswe/PS1dE9 mice, a particularly aggressive transgenic mouse model generated with mutant transgenes for APP (APPswe: KM594/5NL) and PS1 (dE9: deletion of exon 9). Ex vivo histochemistry showed Abeta deposition by 4 months with a progressive increase in plaque number up to 12 months and a similar increase of Abeta levels. In vivo multiphoton microscopy at weekly intervals showed increasing beta-amyloid deposition as CAA and plaques. Although first appearing at an early age, CAA progressed at a significantly slower rate than in the Tg2576 mice. The consistent and early onset of beta-amyloid accumulation in the APPswe/PS1dE9 model confirms its utility for studies of biochemical and pathological mechanisms underlying beta-amyloid deposition, as well as exploring new therapeutic treatments.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2006.08.017

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,627
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,486
Self-citation
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Self-citation
Vascular Cognitive Impairment
O'Brien, J. T., Erkinjuntti, T., Reisberg, ‌., Román, G. C., Pantoni, L., Bowler, J., Ballard, C., DeCarli, C., Gorelick, P., Rockwood, K., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,165

Flagged first, then by citations

Show all 46 references

Sorted by citations

Items 401–500 of 748

A versatile miniature two-photon microscope enabling multicolor deep-brain imaging
Wu, R., Zhao, C., Qiu, S., Zhu, Y., Zhang, L., Fu, Q., Hu, Y., Wu, D., Yu, F., Zhou, F., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02780-6 · Cited by 24
TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis
Zhang, H., Wang, H., Gao, F., Yang, J. Y., Xu, Y., Fu, Y., Cai, M., Zhang, X., Yang, Q., Tong, K., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.020 · Cited by 24
Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice
Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., de la Ossa, L., Aso, E., Gómez-Acero, L., Shigemoto, R., Fukazawa, Y., Ciruela, F., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01078-5 · Cited by 22
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 25
Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long-lasting after treatment discontinuation
Ziyatdinova, S., Viswanathan, J., Hiltunen, M. O., Tanila, H., & Pitkänen, A. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.02.005 · Cited by 23
Nonlinear and vibrational microscopy for label-free characterization of amyloid-β plaques in Alzheimer's disease model
Cunha, R. S., Lafetá, L., Fonseca, E. A., Barbosa, A. S., Romano‐Silva, M. A., Vieira, R. P., Jório, A., & Malard, L. M. (2021) · The Analyst · doi:10.1039/d1an00074h · Cited by 24
Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
Abdulhameed, N., Babin, A., Hansen, K. M., Weaver, R. R., Banks, W. A., Talbot, K., & Rhea, E. M. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01537-1 · Cited by 25
Augmentation of Sensory-Evoked Hemodynamic Response in an Early Alzheimer's Disease Mouse Model
Kim, J.-H., & Jeong, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121900 · Cited by 24
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Lam, S., Hérard, A., Boluda, S., Petit, F., Eddarkaoui, S., Cambon, K., The Brainbank Neuro-CEB Neuropathology Network, Letournel, F., Martin‐Négrier, M., Faisant, M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01410-y · Cited by 29
Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons
Chen, S., Wu, C., Lin, T., Chuang, Y., & Yang, D. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.012 · Cited by 23
Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease
Pedrós, I., Petrov, D., Artiach, G., Abad, S., Ramon‐Duaso, C., Sureda, F. X., Pallàs, M., Beas‐Zárate, C., Folch, J., & Camins, A. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0574-5 · Cited by 23
APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study
Kuhla, A., Rühlmann, C., Lindner, T., Polei, S., Hadlich, S., Krause, B. J., Vollmar, B., & Teipel, S. J. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.06.009 · Cited by 23
Stereological Investigation of the Effects of Treadmill Running Exercise on the Hippocampal Neurons in Middle-Aged APP/PS1 Transgenic Mice
Chao, F., Jiang, L. H., Zhang, Y., Zhou, C., Zhang, L., Tang, J., Liang, X., Qi, Y., Zhu, Y., Ma, J., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171017 · Cited by 25
Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all Aβ Species in the Early Alzheimer’s Disease Model
Ge, Y., Zeng, F., Sun, G., Peng, K., Li, X., Yu, H., Cheng, C., Xu, Y., & Yang, J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00419 · Cited by 23
Estradiol Replacement at the Critical Period Protects Hippocampal Neural Stem Cells to Improve Cognition in APP/PS1 Mice
Qin, Y., An, D., Xu, W., Qi, X., Wang, X., Chen, L., Chen, L., & Sha, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00240 · Cited by 22
PET Imaging for Dynamically Monitoring Neuroinflammation in APP/PS1 Mouse Model Using [18F]DPA714
Hu, W., Pan, D., Wang, Y., Bao, W., Zuo, C., Guan, Y., Hua, F., Yang, M., & Zhao, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00810 · Cited by 22
Dysfunction of striatal MeCP2 is associated with cognitive decline in a mouse model of Alzheimer's disease
Lee, S.-J., Kim, T. K., Choi, J. E., Choi, Y., You, M., Ryu, J., Chun, Y. L., Ham, S., Hyeon, S. J., Ryu, H., et al. (2022) · Theranostics · doi:10.7150/thno.68439 · Cited by 22
Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of A lzheimer's disease
Melief, E. J., Cudaback, E., Jorstad, N. L., Sherfield, E., Postupna, N. O., Wilson, A. M., Darvas, M., Montine, K. S., Keene, C. D., & Montine, T. J. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23592 · Cited by 22
Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects
Klausner, A. P., & Steers, W. D. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0046-0 · Cited by 22
Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice
Tsvetkov, P. O., Cheglakov, I. B., Ovsepyan, A. A., Mediannikov, O., Morozov, A. O., Telegin, G. B., & Kozin, S. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150031 · Cited by 22
Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
Cai, H., Wang, Y., He, J., Cai, T., Wu, J., Fang, J., Zhang, R., Guo, Z., Guan, L., Zhan, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21515 · Cited by 22
Yizhiqingxin Formula Alleviates Cognitive Deficits and Enhances Autophagy via mTOR Signaling Pathway Modulation in Early Onset Alzheimer’s Disease Mice
Yang, Y., Wang, Z., Cao, Y., Liu, J., Li, P., Li, H., & Liu, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01041 · Cited by 22
Limited Clearance of Pre-Existing Amyloid Plaques After Intracerebral Injection of Aβ Antibodies in Two Mouse Models of Alzheimer Disease
Tucker, S. M. F., Borchelt, D., & Troncoso, J. C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31815f38d2 · Cited by 22
Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer’s Disease Model Mice Fed a High-Fat Diet
Matsuda, T., & Hisatsune, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160761 · Cited by 23
Peripheral cancer attenuates amyloid pathology in Alzheimer’s disease via cystatin-c activation of TREM2
Li, X., Tang, X., Zeng, J., Duan, L., Hou, Z., Li, L., Guo, Y., Chai, C., Liu, J., Wang, Y., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.020 · Cited by 21
Reduction of hippocampal N‐acetyl aspartate level in aged APPSwe/PS1dE9 transgenic mice is associated with degeneration of CA3 pyramidal neurons
Xu, W., Zhan, Y., Huang, W., Wang, X., Zhang, S., & Lei, H. C. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22479 · Cited by 20
Oligomeric Forms of Human Amyloid-Beta(1–42) Inhibit Antigen Presentation
Gericke, C., Mallone, A., Engelhardt, B., Nitsch, R. M., & Ferretti, M. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01029 · Cited by 20
Effects of cerebral amyloid angiopathy on the brain vasculome
Deng, W., Guo, S., van Veluw, S. J., Yu, Z., Chan, S. J., Takase, H., Arai, K., Ning, M., Greenberg, S. M., Lo, E. H., et al. (2022) · Aging Cell · doi:10.1111/acel.13503 · Cited by 21
Self-citation
Early death in a mouse model of Alzheimer’s disease exacerbated by microglial loss of TAM receptor signaling
Huang, Y., & Lemke, G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204306119 · Cited by 22
Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer’s Disease: In Vivo Studies on Mouse Models
Jun, J., Moon, H., Yang, S., Lee, J.-H., Baek, J., Kim, H., Cho, H., Hwang, K., Ahn, S., Kim, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00393 · Cited by 21
The effect of cyclodextrin-solubilized curcuminoids on amyloid plaques in Alzheimer transgenic mice: brain uptake and metabolism after intravenous and subcutaneous injection
Quitschke, W. W., Steinhauff, N., & Rooney, J. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt170 · Cited by 21
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP SWE /PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
Reale, M., D’Angelo, C., Costantini, E., Nicola, M. D., Yarla, N. S., Kamal, M. A., Salvador, N., & Perry, G. L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170999 · Cited by 21
GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?
Bengtsson, S. K. S., Bäckström, T. C., Brinton, R. D., Irwin, R. W., Johansson, M., Sjöstedt, J., & Wang, M. D. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100206 · Cited by 22
CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice
Chen, F., Fang, S., Du, Y., Ghosh, A., Reed, M. N., Long, Y., Suppiramaniam, V. D., Tang, S., & Hong, H. (2021) · Aging · doi:10.18632/aging.202501 · Cited by 21
Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice
Gómez‐Murcia, V., Launay, A., Carvalho, K., Burgard, A., Mériaux, C., Caillierez, R., Eddarkaoui, S., Kilinc, D., Siedlecki‐Wullich, D., Besegher, M., et al. (2024) · Brain · doi:10.1093/brain/awae113 · Cited by 22
Exogenous Short Chain Fatty Acid Effects in APP/PS1 Mice
Zajac, D. J., Shaw, B. C., Braun, D. J., Green, S. J., Morganti, J. M., & Estus, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.873549 · Cited by 21
Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer’s Disease
Lin, C.-Y., Cheng, Y.-S., Liao, T., Lin, C. W., Chen, Z.-T., Twu, W.-I., Chang, C., Tan, D. T.-W., Liu, R.-S., Tu, P., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151024 · Cited by 20
Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo
Serrano‐Pozo, A., Sánchez-García, M. A., Heras‐Garvin, A., March‐Díaz, R., Navarro, V., Vizuete, M., López‐Barneo, J., Vitórica, J., & Pascual, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170345 · Cited by 20
Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
Arredondo, S. B., Reyes, D. T., Herrera-Soto, A., Mardones, M. D., Inestrosa, N. C., & Varela‐Nallar, L. (2021) · Scientific Reports · doi:10.1038/s41598-021-01977-x · Cited by 20
Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer’s Disease
Emmerzaal, T. L., Rodenburg, R. J., Tanila, H., Verweij, V., Kiliaan, A. J., & Kozicz, T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180337 · Cited by 21
Intrahippocampal Inoculation of Aβ1–42 Peptide in Rat as a Model of Alzheimer’s Disease Identified MicroRNA-146a-5p as Blood Marker with Anti-Inflammatory Function in Astrocyte Cells
Aquino, R., de Concini, V., Dhénain, M., Lam, S., Gosset, D., Baquedano, L., Forero, M. G., Menuet, A., Baril, P., & Pichon, C. (2023) · Cells · doi:10.3390/cells12050694 · Cited by 21
Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid
Shen, L., Han, B., Geng, Y., Wang, J., Wang, Z., & Wang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174763 · Cited by 19
Locomotor activity, emotionality, sensori-motor gating, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
O’Leary, T. P., Hussin, A. T., Gunn, R. K., & Brown, R. E. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.05.021 · Cited by 18
In Vivo Two Photon Imaging of Astrocytic Structure and Function in Alzheimer’s Disease
Kelly, P., Hudry, E., Hou, S. S., & Bacskai, B. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00219 · Cited by 20
Self-citation
Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer’s Disease
Kozin, S. A., Barykin, E. P., Telegin, G. B., Чернов, А. С., Adzhubei, A. A., Radko, S. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00518 · Cited by 20
A Longitudinal Study of Cognition, Proton MR Spectroscopy and Synaptic and Neuronal Pathology in Aging Wild-type and AβPPswe-PS1dE9 Mice
Jansen, D., Zerbi, V., Janssen, C. I. F., Dederen, P. J. W. C., Mutsaers, M. P. C., Hafkemeijer, A., Janssen, A.-L., Nobelen, C. L. M., Veltien, A. A., van Asten, J. J. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063643 · Cited by 19
Deficits in object-in-place but not relative recency performance in the APPswe/PS1dE9 mouse model of Alzheimer’s disease: Implications for object recognition
Bonardi, C., Pardon, M., & Armstrong, P. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.07.008 · Cited by 17
Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes
Vargas-Soria, M., Ramos‐Rodríguez, J. J., del Marco, À., Hierro‐Bujalance, C., Carranza-Naval, M. J., Calvo-Rodríguez, M., van Veluw, S. J., Stitt, A. W., Simó, R., Bacskai, B. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00380-6 · Cited by 20
Self-citation
Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition
Roy, M., Cardoso, C., Dorieux, O., Malgorn, C., Epelbaum, S., Petit, F., Kraska, A., Brouillet, E., Delatour, B., Perret, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.017 · Cited by 21
New nicotinic analogue ZY-1 enhances cognitive functions in a transgenic mice model of Alzheimer's disease
Nie, H., Wang, Z., Zhao, W., Lu, J., Zhang, C. M., Lok, K., Wang, Y., Shen, H., Zheng, X., & Yin, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.001 · Cited by 18
Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1–42-injected rats and APP/PS1 transgenic mice
Li, P., Wang, W., Liu, Z., Xu, S., Lu, W., Wang, L., & Wang, X. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.29 · Cited by 18
Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model
Wang, C., Iashchishyn, I. A., Kara, J. A., Foderà, V., Vetri, V., Sancataldo, G., Marklund, N., & Morozova‐Roche, L. A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.012 · Cited by 18
Cell proliferation and neurogenesis alterations in Alzheimer’s disease and diabetes mellitus mixed murine models
Hierro‐Bujalance, C., del Marco, À., Ramos‐Rodríguez, J. J., Infante‐Garcia, C., Gomez‐Santos, S. B., Herrera, M., & Garcı́a-Alloza, M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14987 · Cited by 19
Immunological alteration & toxic molecular inductions leading to cognitive impairment & neurotoxicity in transgenic mouse model of Alzheimer's disease
Ahuja, M., Buabeid, M. A., Abdel‐Rahman, E. A., Majrashi, M., Parameshwaran, K., Amin, R., Ramesh, S., Kariharan, T., Pondugula, S. R., Suppiramaniam, V. D., et al. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.03.004 · Cited by 18
Retinal Levels of Amyloid Beta Correlate with Cerebral Levels of Amyloid Beta in Young APPswe/PS1dE9 Transgenic Mice before Onset of Alzheimer’s Disease
Mei, X., Yang, M., Zhu, L., Zhou, Q., Li, X., Chen, Z., & Zou, C. (2020) · Behavioural Neurology · doi:10.1155/2020/1574816 · Cited by 18
Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease
Jiang, N., Cupolillo, D., Grosjean, N., Muller, E., Deforges, S., Mulle, C., & Amédée, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105345 · Cited by 17
Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
Plano, L. M. D., Saitta, A., Oddo, S., & Caccamo, A. (2024) · Biomolecules · doi:10.3390/biom14111405 · Cited by 22
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
Catania, M., Colombo, L., Sorrentino, S., Cagnotto, A., Lucchetti, J., Barbagallo, M., Vannetiello, I., Vecchi, E. R., Favagrossa, M., Costanza, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01745-x · Cited by 18
Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
Drew, V. J., Wang, C., & Kim, T. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119810 · Cited by 19
T cell mediated cerebral hemorrhages and microhemorrhages during passive Aβ immunization in APPPS1 transgenic mice
Meyer‐Luehmann, M., Mora, J. R., Mielke, M. L., Spires‐Jones, T. L., de Calignon, A., von Andrian, U. H., & Hyman, B. T. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-22 · Cited by 17
Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APPswe/PS1dE9 transgenic mice: Effect of long-term treatment with paroxetine
Olesen, L. Ø., Sivasaravanaparan, M., Severino, M., Babcock, A. A., Bouzinova, E. V., West, M. J., Wiborg, O., & Finsen, B. R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.04.021 · Cited by 17
Effects of ovarian hormone loss on neuritic plaques and autophagic flux in the brains of adult female APP/PS1 double-transgenic mice
Yao, Q., Feng, M. H., Yang, B., Long, Z., Luo, S., Luo, M., He, G., & Wang, K. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy032 · Cited by 17
Circulating Plasma microRNAs are Altered with Amyloidosis in a Mouse Model of Alzheimer’s Disease
Ryan, M. M., Guévremont, D., Mockett, B. G., Abraham, W. C., & Williams, J. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180385 · Cited by 20
Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B)
Midani-Kurçak, J. S., Dinekov, M., Puladi, B., Arzberger, T., & Köhler, C. N. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.008 · Cited by 17
Age, but Not Amyloidosis, Induced Changes in Global Levels of Histone Modifications in Susceptible and Disease-Resistant Neurons in Alzheimer’s Disease Model Mice
Dyer, M. S., Phipps, A. J., Mitew, S., Taberlay, P. C., & Woodhouse, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00068 · Cited by 16
Toward a Dynamic Biomarker Model in Alzheimer's Disease
Mouiha, A., Initiative, T. A. D. N., & Duchesne, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111367 · Cited by 18
Neurotransmitters and Energy Metabolites in Amyloid-Bearing APPSWE×PSEN1dE9 Mouse Brain
Hartmann, J., Kiewert, C., & Klein, J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161091 · Cited by 17
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs
Jin, N., Ziyatdinova, S., Gureviciene, I., & Tanila, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-68845-y · Cited by 17
Transcriptomic and functional analysis of Aβ1-42 oligomer-stimulated human monocyte-derived microglia-like cells
Smit, T., Ormel, P. R., Sluijs, J. A., Hulshof, L. A., Middeldorp, J., de Witte, L. D., Hol, E. M., & Donega, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.001 · Cited by 16
Hypothalamic-pituitary-adrenal (HPA) axis activity and anxiety-like behavior during aging: A test of the glucocorticoid cascade hypothesis in amyloidogenic APPswe/PS1dE9 mice
Harris, B. N., Roberts, B. R., DiMarco, G. M., Maldonado, K. A., Okwunwanne, Z., Savonenko, A. V., & Soto, P. L. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114126 · Cited by 19
Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention
Gonçalves, M., Costa, M., Paiva‐Martins, F., & Silva, P. (2024) · Molecules · doi:10.3390/molecules29204841 · Cited by 17
Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice
Collins, J. M., King, A. E., Woodhouse, A., Kirkcaldie, M., & Vickers, J. C. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.5982 · Cited by 16
Comparing the effect of the novel ionic cocrystal of lithium salicylate proline (LISPRO) with lithium carbonate and lithium salicylate on memory and behavior in female APPswe/PS1dE9 Alzheimer's mice
Habib, A., Shytle, R. D., Sawmiller, D. R., Koilraj, S., Munna, S. A., Rongo, D., Hou, H., Borlongan, C. V., Currier, G. W., & Tan, J. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24438 · Cited by 16
Accumulation of Amyloid Beta (Aβ) Peptide on Blood Vessel Walls in the Damaged Brain after Transient Middle Cerebral Artery Occlusion
Martins, A., Zayas‐Santiago, A., Ferrer‐Acosta, Y., Martinez-Jimenez, S. M., Zueva, L. V., Díaz-García, A., & Inyushin, M. Y. (2019) · Biomolecules · doi:10.3390/biom9080350 · Cited by 17
Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia
Shabir, O., Moll, T., Matuszyk, M. M., Eyre, B., Dake, M. D., Berwick, J., & Francis, S. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111361 · Cited by 17
Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains
The Brainbank Neuro-CEB Neuropathology Network, Hérard, A., Petit, F., Gary, C., Guillermier, M., Boluda, S., Garin, C. M., Lam, S., & Dhénain, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01081-7 · Cited by 16
Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
He, Z., You, G., Liu, Q., & Li, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111931 · Cited by 16
Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer’s Disease
Papazoglou, A., Soós, J., Lundt, A., Wormuth, C., Ginde, V. R., Müller, R., Henseler, C., Broich, K., Xie, K., Ehninger, D., et al. (2016) · Neural Plasticity · doi:10.1155/2016/7167358 · Cited by 18
Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models
Pagnier, G. J., Kastanenka, K. V., Sohn, M., Choi, S., Choi, S.-H., Soh, H., & Bacskai, B. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0338-2 · Cited by 20
Self-citation
Downregulation of Aquaporin 9 Exacerbates Beta-amyloid-induced Neurotoxicity in Alzheimer’s Disease Models In vitro and In vivo
Liu, J., Chen, X. L., Chen, H., Shi, J., Leung, G., Tang, S. C. W., Lao, L., Yip, H. K.-F., Lee, C., Sze, S. C. W., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.016 · Cited by 16
Cerebral metabolism in a mouse model of Alzheimer’s disease characterized by two-photon fluorescence lifetime microscopy of intrinsic NADH
Gómez, C. A., Fu, B., Sakadžić, S., & Yaseen, M. A. (2018) · Neurophotonics · doi:10.1117/1.nph.5.4.045008 · Cited by 15
Mechanical alterations of the hippocampus in the APP/PS1 Alzheimer’s disease mouse model
Antonovaité, N., Hulshof, L. A., Huffels, C. F. M., Hol, E. M., Wadman, W. J., & Iannuzzi, D. (2021) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2021.104697 · Cited by 15
Behavioral and neuropathological consequences of transient global ischemia in APP/PS1 Alzheimer model mice
Kemppainen, S., Hämäläinen, E., Miettinen, P. O., Koıstınaho, J., & Tanila, H. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.050 · Cited by 15
Magnetic resonance T2 relaxation time at 7 Tesla associated with amyloid β pathology and age in a double-transgenic mouse model of Alzheimer’s disease
Li, L., Wang, X., Gao, F., Wang, L., Xia, R., Li, Z., Wu, X., Tang, B., Zeng, Y., Zhou, G., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.058 · Cited by 16
Heterozygous knockout of cytosolic phospholipase A2α attenuates Alzheimer’s disease pathology in APP/PS1 transgenic mice
Qu, B., Gong, Y., Gill, J. M., Kenney, K., & Diaz-Arrastia, R. R. (2017) · Brain Research · doi:10.1016/j.brainres.2017.06.021 · Cited by 15
Micro-Raman spectroscopy of lipid halo and dense-core amyloid plaques: aging process characterization in the Alzheimer's disease APPswePS1ΔE9 mouse model
Fonseca, E. A., Lafetá, L., Campos, J. L. E., Cunha, R. S., Barbosa, A. S., Romano‐Silva, M. A., Vieira, R. P., Malard, L. M., & Jório, A. (2021) · The Analyst · doi:10.1039/d1an01078f · Cited by 15
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14
Cerebrovascular Dysfunction in Alzheimer’s Disease and Transgenic Rodent Models
Fang, X., Fan, F., & Roman, R. J. (2024) · Journal of Experimental Neurology · doi:10.33696/neurol.5.087 · Cited by 17
Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer’s disease
Yang, H., Yang, H., Xie, Z., Wang, P., & Bi, J. (2014) · Neurological Research · doi:10.1179/1743132814y.0000000417 · Cited by 14
Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer’s Disease
Fu, Y., Zhao, D., Pan, B., Wang, J., Cui, Y., Shi, F., Wang, C., Yin, X., Zhou, X., & Yang, L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150312 · Cited by 14
Calmodulin‐like skin protein protects against spatial learning impairment in a mouse model of Alzheimer disease
Kusakari, S., Nawa, M., Sudo, K., & Matsuoka, M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14258 · Cited by 14
Development of a PET radioligand selective for cerebral amyloid angiopathy
Abrahamson, E. E., Stehouwer, J. S., Vazquez, A. L., Huang, G., Mason, N. S., Lopresti, B. J., Klunk, W. E., Mathis, C. A., & Ikonomović, M. D. (2020) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2020.05.001 · Cited by 13
Unraveling Early Signs of Navigational Impairment in APPswe/PS1dE9 Mice Using Morris Water Maze
Karunakaran, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.568200 · Cited by 16
Immunization with Aβ3-10-KLH vaccine improves cognitive function and ameliorates mitochondrial dysfunction and reduces Alzheimer’s disease-like pathology in Tg-APPswe/PSEN1dE9 mice
Zhang, X., Meng, Y., Yan, X., Liu, S., Wang, G., & Cao, Y. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.019 · Cited by 14
Gene Expression Analysis of the Endocannabinoid System in Presymptomatic APP/PS1 Mice
Vidal-Palencia, L., Ramon‐Duaso, C., González-Parra, J. A., & Busquets-García, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.864591 · Cited by 16
Presenilin and APP Regulate Synaptic Kainate Receptors
Barthet, G., Moreira-de-Sá, A., Zhang, P., Deforges, S., Castanheira, J., Gorlewicz, A., & Mulle, C. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0297-22.2022 · Cited by 14
Prospects for Early Detection of Alzheimers Disease from Serial MR Images in Transgenic Mouse Models
Muskulus, M., Scheenstra, A. E. H., Braakman, N., Dijkstra, J., Lunel, S. M. V., Alia, A., de Groot, H. J. M., & Reiber, J. H. C. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147089 · Cited by 14
Pterostilbene attenuates amyloid-β induced neurotoxicity with regulating PDE4A-CREB-BDNF pathway.
Meng, J., Chen, Y., Bi, F., Li, H., Chang, C., & Liu, W. (2019) · Europe PMC (PubMed Central) · Cited by 14
Nutraceuticals and their Derived Nano-Formulations for the Prevention and Treatment of Alzheimer's Disease
Haque, S. E., Iqubal, A., Iqubal, M. K., Fazal, S. A., & Pottoo, F. H. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210309115605 · Cited by 14
Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease
Timmer, N., Herbert, M. K., Kleinovink, J. W., Kiliaan, A. J., de Waal, R. M. W., & Verbeek, M. M. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01091.x · Cited by 14

Authors: Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P.
Affiliations: Harvard University (US)
Corresponding author: Frosch, Matthew P.
ORCID: Robbins, Elissa M.
Zhang-Nunes, Sandy X.
Betensky, Rebecca A.
Greenberg, Steven M.
Bacskai, Brian J.
Frosch, Matthew P.
Venue: Neurobiology of Disease
Publisher: Elsevier BV
Published: 2006-12
Volume: 24
Issue: 3
Pages: 516-524
ISSN: 0969-9961 (ISSN-L)
DOI: 10.1016/j.nbd.2006.08.017
OpenAlex: W2005719973
Cited by: 744
References: 46
Citations by year: 2026: 36 · 2025: 28 · 2024: 39 · 2023: 28 · 2022: 41 · 2021: 46 · 2020: 53 · 2019: 43 · 2018: 57 · 2017: 44 · 2016: 45 · 2015: 49 · 2014: 47 · 2013: 51 · 2012: 42
FWCI: 10.38
Type: journal article
Language: en
Open access: green
doaj.org
Licence: cc-by-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Disease (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Chinese Academy of Agricultural Sciences
National Institutes of Health
National Institute on Aging (R01AG021084, AG021084, R01AG020570, AG 020570)
National Institute of Biomedical Imaging and Bioengineering (EB 000768, R01EB000768)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: amyloid-beta deposition, APP/PS1 mice, Alzheimer's disease, transgenic mouse model, amyloid plaques, cerebral amyloid angiopathy, multiphoton microscopy, Tg2576 mice
MeSH terms: Age Factors, Alzheimer Disease, Animals, Brain, Disease Models, Animal, Mice, Neurologic Mutants, Mice, Transgenic, Tissue Distribution, Amyloid beta-Protein Precursor, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks